You are here

Portage Biotech Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
PBT.U
CSE Index: 
Currency: 

Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.

You are here

Portage Biotech Inc. (PBT.U)

SEDAR Information

Company Info

Address
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
Phone
416-929-1806
Fax
416-929-6612
Email
ks@portagebiotech.com
Listing date
Monday, October 28, 2013

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
1,085,789,697
Reserved for Issuance: 
595,842

Company Officers

Kam Shah, Chief Financial Officer and director
Dr. Gregory Bailey, Chairman
Dr. Ian Walters, Chief Executive Officer

Bulletins

08/02/2019

2019-0219 – Fundamental Change - Portage Biotech Inc. (PBT.U)

Le 8 février/February 2019

Portage Biotech Inc. has requalified for listing following a fundamental change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

06_23_CannaVest_West_Website_V2

CannaVest West

Monday, July 22, 2019 (All day) to Tuesday, July 23, 2019 (All day)
07_25_GritCAMP_2019_Website

GritCAMP 2019

Thursday, July 25, 2019 (All day) to Friday, July 26, 2019 (All day)
08_07_Cannacord_Genuity_39th_Annual_Growth_Conference_Website

Canaccord Genuity 39th Annual Growth Conference

Wednesday, August 7, 2019 (All day) to Thursday, August 8, 2019 (All day)